BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
29 August 2025 (07:00 - 18:00)
Organised by: 
ESC TV
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
11 More presentations in this session
Access the full session
The Event
ESC Congress 2025
29 August - 1 September 2025
You may be interested in
Congress Presentation
Congress Session
